Blood Res 2015; 50(1):
Published online March 31, 2015
https://doi.org/10.5045/br.2015.50.1.33
© The Korean Society of Hematology
Department of Pediatrics, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Correspondence to : Correspondence to Nack-Gyun Chung, M.D., Ph.D. Department of Pediatrics, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-6188, Fax: +82-2-537-4544, cngped@catholic.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although deferasirox (DFX) is reported to have anti-tumor effects, its anti-leukemic activity remains unclear. We evaluated the effect of DFX treatment on two murine lymphoid leukemia cell lines, and clarified the mechanisms underlying its potential anti-leukemic activity.
L1210 and A20 murine lymphoid leukemia cell lines were treated with DFX. Cell viability and apoptosis were evaluated by the 3-(4,5-dimethylthaizol-2-yl)-5-(3-carboxymethylphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and fluorescence-activated cell sorting (FACS) analysis, respectively. Immunoblotting was performed to detect the expression of key apoptotic proteins.
In dose- and time-dependent manner, DFX decreased viability and increased apoptosis of murine leukemic cells. Fas expression was significantly higher in A20 cells than in L1210 cells at all DFX concentrations tested. Although both cell lines exhibited high caspase 3 and caspase 9 expression, a critical component of the intrinsic mitochondrial apoptotic pathway, expression was greater in L1210 cells. In contrast, caspase 8, a key factor in the extrinsic apoptotic pathway, showed greater expression in A20 cells. Cytochrome c expression was significantly higher in L1210 cells. In both cell lines, co-treatment with ferric chloride and DFX diminished the expression of these intracellular proteins, as compared to DFX treatment alone.
Treatment with DFX increased caspase-dependent apoptosis in two murine lymphoid leukemia cell lines, with differing apoptotic mechanisms in each cell line.
Keywords Lymphoid leukemia, Deferasirox, Apoptosis, Caspase
Blood Res 2015; 50(1): 33-39
Published online March 31, 2015 https://doi.org/10.5045/br.2015.50.1.33
Copyright © The Korean Society of Hematology.
Sol-Rim Jeon, Jae-Wook Lee, Pil-Sang Jang, Nack-Gyun Chung*, Bin Cho, and Dae-Chul Jeong
Department of Pediatrics, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Correspondence to: Correspondence to Nack-Gyun Chung, M.D., Ph.D. Department of Pediatrics, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-6188, Fax: +82-2-537-4544, cngped@catholic.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although deferasirox (DFX) is reported to have anti-tumor effects, its anti-leukemic activity remains unclear. We evaluated the effect of DFX treatment on two murine lymphoid leukemia cell lines, and clarified the mechanisms underlying its potential anti-leukemic activity.
L1210 and A20 murine lymphoid leukemia cell lines were treated with DFX. Cell viability and apoptosis were evaluated by the 3-(4,5-dimethylthaizol-2-yl)-5-(3-carboxymethylphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and fluorescence-activated cell sorting (FACS) analysis, respectively. Immunoblotting was performed to detect the expression of key apoptotic proteins.
In dose- and time-dependent manner, DFX decreased viability and increased apoptosis of murine leukemic cells. Fas expression was significantly higher in A20 cells than in L1210 cells at all DFX concentrations tested. Although both cell lines exhibited high caspase 3 and caspase 9 expression, a critical component of the intrinsic mitochondrial apoptotic pathway, expression was greater in L1210 cells. In contrast, caspase 8, a key factor in the extrinsic apoptotic pathway, showed greater expression in A20 cells. Cytochrome c expression was significantly higher in L1210 cells. In both cell lines, co-treatment with ferric chloride and DFX diminished the expression of these intracellular proteins, as compared to DFX treatment alone.
Treatment with DFX increased caspase-dependent apoptosis in two murine lymphoid leukemia cell lines, with differing apoptotic mechanisms in each cell line.
Keywords: Lymphoid leukemia, Deferasirox, Apoptosis, Caspase
Viability of L1210 (
Measurement of apoptosis in L1210 (
Measurement of CD95 (Fas) expression in L1210 and A20 cells after 24 h DFX treatment with or without FeCl3, according to DFX concentration (12.5-50 µM). Experiments were performed in triplicate. All data are presented as the mean±standard error (a)
Western blot measurement of caspase 3, caspase 9, caspase 8, PARP, and BAX expression in L1210 (
Western blot measurement of cytochrome c expression in L1210 (
Jong Gwon Choi, Jung-Lim Kim, Joohee Park, Soonwook Lee, Seh Jong Park, Jun Suk Kim, and Chul Won Choi
Korean J Hematol 2012; 47(3): 194-201Shilpa Sarvothaman, Ram Babu Undi, Satya Ratan Pasupuleti, Usha Gutti, and Ravi Kumar Gutti
Blood Res 2015; 50(2): 73-79Kyeong Bae Park, Dae Sik Hong, Won Suk Suh, Nam Soo Lee, Sung Gyu Park, Jong Ho Won, Hee Jung Jung, Sook Ja Kim, Young Seon Hong, Jong Youl Jin, Hee Sook Park, Sang Man Shin
Korean J Hematol 2002; 37(3): 200-211
Viability of L1210 (
Measurement of apoptosis in L1210 (
Measurement of CD95 (Fas) expression in L1210 and A20 cells after 24 h DFX treatment with or without FeCl3, according to DFX concentration (12.5-50 µM). Experiments were performed in triplicate. All data are presented as the mean±standard error (a)
Western blot measurement of caspase 3, caspase 9, caspase 8, PARP, and BAX expression in L1210 (
Western blot measurement of cytochrome c expression in L1210 (